Clinical and pathologic findings of paraneoplastic dermatoses

Journal of the American Academy of Dermatology

Volumn 54, Issue 5, 2006, Pages 745-762

  Chung, Vinh Q ^a   Moschella, Samuel L ^b   Zembowicz, Artur ^a   Liu, Vincent ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADENOCARCINOMA; AMYLOIDOSIS; CLINICAL FEATURE; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE COURSE; ERYTHEMA; HISTOLOGY; HODGKIN DISEASE; HUMAN; HYPERTRICHOSIS; ICHTHYOSIS; KERATOSIS PALMARIS; LUNG CARCINOMA; NECROBIOTIC DISORDER; ONYCHOLYSIS; PARANEOPLASTIC SYNDROME; PATHOGENICITY; PEMPHIGUS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RETICULOHISTIOCYTOSIS; REVIEW; SCLEROMYXEDEMA; SEBORRHEIC KERATOSIS; SKIN DISEASE; STOMACH CARCINOMA; XANTHOGRANULOMA;

DEMOGRAPHY; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PROGNOSIS; SKIN DISEASES;

EID: 33646104686     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.06.051     Document Type: Review

References (106)

1. Poole S., and Fenske N.A. Cutaneous markers of internal malignancy. II. Paraneoplastic dermatoses and environmental carcinogens. [comment]. J Am Acad Dermatol 28 (1993) 147-164
2. Curth H.O. Skin lesions and internal carcinoma. In: Andrade R., Gumport S.L., Popkin G.L., and rees T.D. (Eds). Cancer of the skin: biology-diagnosis-management (1976), Saunders, Philadelphia 1308-1341
3. McLean D.I. Cutaneous paraneoplastic syndromes. Arch Dermatol 122 (1986) 765-767
4. Brenner S., Tamir E., Maharshak N., and Shapira J. Cutaneous manifestations of internal malignancies. Clin Dermatol 19 (2001) 290-297
5. Robinson N.D., Hashimoto T., Amagai M., and Chan L.S. The new pemphigus variants. [comment]. J Am Acad Dermatol 40 (1999) 649-671 quiz 672-3
6. Boyce S., and Harper J. Paraneoplastic dermatoses. Dermatol Clin 20 (2002) 523-532
7. Kurzrock R., and Cohen P.R. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 99 (1995) 662-671
8. Cohen P.R., and Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin Oncol 24 (1997) 334-359
9. Sabir S., James W.D., and Schuchter L.M. Cutaneous manifestations of cancer. Curr Opin Oncol 11 (1999) 139-144
10. Yeh J.S., Munn S.E., Plunkett T.A., et al. Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol 42 (2000) 357-362
11. Pollitzer S. Acanthosis nigricans: a symptom of a disorder of the sympathetic. JAMA 53 (1909) 1369-1373
12. Sedano H.O., and Gorlin R.J. Acanthosis nigricans. Oral Surg Oral Med Oral Pathol 63 (1987) 462-467
13. Skiljevic D.S., Nikolic M.M., Jakovljevic A., and Dobrosavljevic D.D. Generalized acanthosis nigricans in early childhood. Pediatr Dermatol 18 (2001) 213-216
14. Cohen P.R. Cutaneous paraneoplastic syndromes. Am Fam Physician 50 (1994) 1273-1282
15. Higgins E.M., and du Vivier A.W. Cutaneous manifestations of malignant disease. Br J Hosp Med 48 (1992) 552-554 558-61
16. Bottoni U., Dianzani C., Pranteda G., et al. Florid cutaneous and mucosal papillomatosis with acanthosis nigricans revealing a primary lung cancer. J Eur Acad Dermatol Venereol 14 (2000) 205-208
17. Rogers D.L. Acanthosis nigricans. Semin Dermatol 10 (1991) 160-163
18. Stuart C.A., Driscoll M.S., Lundquist K.F., et al. Acanthosis nigricans. J Basic Clin Physiol Pharmacol 9 (1998) 407-418
19. Ramirez-Amador V., Esquivel-Pedraza L., Caballero-Mendoza E., Berumen-Campos J., Orozco-Topete R., and Angeles-Angeles A. Oral manifestations as a hallmark of malignant acanthosis nigricans. J Oral Pathol Med 28 (1999) 278-281
20. Schwartz R.A., and Williams M.L. Acquired ichthyosis: a marker for internal disease. Am Fam Physician 29 (1984) 181-184
21. Kurzrock R., and Cohen P.R. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. [comment]. Am J Med 99 (1995) 207-216
22. Cather J.C., and Cohen P.R. Ichthyosiform sarcoidosis. J Am Acad Dermatol 40 (1999) 862-865
23. Politi Y., Ophir J., and Brenner S. Cutaneous paraneoplastic syndromes. [comment]. Acta Derm Venereol 73 (1993) 161-170
24. Haste A.R. Acquired ichthyosis from breast cancer. Br Med J 4 (1967) 96
25. Rizos E., Milionis H.J., Pavlidis N., and Elisaf M.S. Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin's disease. Lancet Oncol 3 (2002) 727
26. Clarke J. Malignant acanthosis nigricans. Clin Exp Dermatol 2 (1977) 167-170
27. Breathnach S.M., and Wells G.C. Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol 5 (1980) 181-189
28. Requena L., Aguilar A., Renedo G., et al. Tripe palms: a cutaneous marker of internal malignancy. J Dermatol 22 (1995) 492-495
29. Cohen P.R., Grossman M.E., Almeida L., and Kurzrock R. Tripe palms and malignancy. J Clin Oncol 7 (1989) 669-678
30. Braverman I.M. Skin manifestations of internal malignancy. Clin Geriatr Med 18 (2002) 1-19
31. Lo W.L., and Wong C.K. Tripe palms: a significant cutaneous sign of internal malignancy. Dermatology 185 (1992) 151-153
32. Leser E. Ueber ein die Krebskrankheit beim Menschen haufig begleitendes, noch wenig gekanntes Symptom. Munchener Med Wochenschr 51 (1901) 2035-2036
33. Heaphy Jr. M.R., Millns J.L., and Schroeter A.L. The sign of Leser-Trelat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 43 (2000) 386-390
34. Holdiness M.R. The sign of Leser-Trelat. Int J Dermatol 25 (1986) 564-572
35. Schwartz R.A. Sign of Leser-Trelat. [comment]. J Am Acad Dermatol 35 (1996) 88-95
36. Bazex A., and Griffiths A. Acrokeratosis paraneoplastica-a new cutaneous marker of malignancy. Br J Dermatol 103 (1980) 301-306
37. Sarkar B., Knecht R., Sarkar C., and Weidauer H. Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol 255 (1998) 205-210
38. Bolognia J.L., Brewer Y.P., and Cooper D.L. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine 70 (1991) 269-280
39. Richard M., and Giroux J.M. Acrokeratosis paraneoplastica (Bazex' syndrome). J Am Acad Dermatol 16 (1987) 178-183
40. Stertz G. Polymyositis. Berl Klin Wochenschr 53 (1916) 489
41. Kankeleit-Uber primaire nichteitrige polymyositis. Dtsch Arch Klin Med 120 (1916) 335-339
42. Barnes B.E., and Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 84 (1976) 68-76
43. Caldwell D.S., and McCallum R.M. Rheumatologic manifestations of cancer. Med Clin North Am 70 (1986) 385-417
44. Cox N.H., Lawrence C.M., Langtry J.A., and Ive F.A. Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy. Arch Dermatol 126 (1990) 61-65
45. Sigurgeirsson B., Lindelof B., Edhag O., and Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326 (1992) 363-367
46. Thivolet J. Pemphigus: past, present and future. Dermatology 189 Suppl 2 (1994) 26-29
47. Anhalt G.J., Kim S.C., Stanley J.R., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323 (1990) 1729-1735
48. Sklavounou A., and Laskaris G. Paraneoplastic pemphigus: a review. Oral Oncol 34 (1998) 437-440
49. Anhalt G.J. Paraneoplastic pemphigus. Adv Dermatol 12 (1997) 77-96 discussion, 97
50. Gammel J.A. Erythema gyratum repens. Arch Dermatol Syph 66 (1953) 494-505
51. Boyd A.S., Neldner K.H., and Menter A. Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol 26 (1992) 757-762
52. Lomholt H., and Thestrup-Pedersen K. Paraneoplastic skin manifestations of lung cancer. Acta Derm Venereol 80 (2000) 200-202
53. Eubanks L.E., McBurney E., and Reed R. Erythema gyratum repens. Am J Med Sci 321 (2001) 302-305
54. White Jr. J.W. Gyrate erythema. Dermatol Clin 3 (1985) 129-139
55. Becker S.W., Kahn D., and Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syph 45 (1942) 1069-1080
56. Marinkovich M.P., Botella R., Datloff J., and Sangueza O.P. Necrolytic migratory erythema without glucagonoma in patients with liver disease. [comment]. J Am Acad Dermatol 32 (1995) 604-609
57. Parker C.M., Hanke C.W., Madura J.A., and Liss E.C. Glucagonoma syndrome: case report and literature review. J Dermatol Surg Oncol 10 (1984) 884-889
58. Wilkinson D.S. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St. Johns Hosp Soc 59 (1973) 244-250
59. Thorisdottir K., Camisa C., Tomecki K.J., and Bergfeld W.F. Necrolytic migratory erythema: a report of three cases. J Am Acad Dermatol 30 (1994) 324-329
60. Chastain M.A. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 321 (2001) 306-320
61. Kasper C.S. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review. Cutis 49 (1992) 120-122 125-8
62. Mullans E.A., and Cohen P.R. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol 38 (1998) 866-873
63. Caughman W., Stern R., and Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol 9 (1983) 751-758
64. Sweet R.D. An acute febrile neutrophilic dermatosis. Br J Dermatol 76 (1964) 349-356
65. Cohen P.R., Talpaz M., and Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 6 (1988) 1887-1897
66. Fitzgerald R.L., McBurney E.I., and Nesbitt Jr. L.T. Sweet's syndrome. Int J Dermatol 35 (1996) 9-15
67. Burrall B. Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J 5 (1999) 8
68. Cohen P.R., Holder W.R., Tucker S.B., Kono S., and Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 72 (1993) 2723-2731
69. Cohen P.R. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: an oxymoron or an epiphenomenon?. [comment]. Arch Dermatol 138 (2002) 400-403
70. Cohen P.R., and Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 42 (2003) 761-778
71. Cohen PR. Sweet's syndrome. Orphanet Encyclopedia. October 2003. Available at: http://www.orpha.net/data/patho/GB/uk-Sweet.pdf. Accessed April 2004.
72. Brocq L. Nouvelle contribution a l'etude du phagedenisme geometrique. Ann Dermatol Syphiligr (Paris) 6 (1916) 195-198
73. Bennett M.L., Jackson J.M., Jorizzo J.L., Fleischer Jr. A.B., White W.L., and Callen J.P. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79 (2000) 37-46
74. Boh E.E., and al-Smadi R.M. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin 20 (2002) 533-546
75. Cohen P.R. Paraneoplastic dermatopathology: cutaneous paraneoplastic syndromes. Adv Dermatol 11 (1996) 215-252 discussion, 253
76. Weber F.P., and Freudenthal W. Nodular non-diabetic cutaneous xanthomatosis with hypercholesterolemia and atypical histological features. Proc R Soc Med 30 (1937) 522-526
77. Barrow M.V., and Holubar K. Multicentric reticulohistiocytosis- a review of 33 patients. Medicine 48 (1969) 287-305
78. Luz F.B., Gaspar T.A.P., Kalil-Gaspar N., and Ramos-e-Silva M. Multicentric reticulohistiocytosis. J Eur Acad Dermatol Venereol 15 (2001) 524-531
79. Goette D.K., Odom R.B., and Fitzwater J.E. Diffuse cutaneous reticulohistiocytoma. Arch Dermatol 118 (1982) 173-176
80. Lesher Jr. J.L., and Allen B.S. Multicentric reticulohistiocytosis. J Am Acad Dermatol 11 (1984) 713-723
81. Snow J.L., and Muller S.A. Malignancy-associated multicentric reticulohistiocytosis: a clinical, histological and immunophenotypic study. Br J Dermatol 133 (1995) 71-76
82. Kossard S., and Winkelmann R.K. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 3 (1980) 257-270
83. Betts C.M., Pasquinelli G., Costa A.M., et al. Necrobiotic xanthogranuloma without periorbital involvement: an ultrastructural investigation. Ultrastruct Pathol 25 (2001) 437-444
84. Ugurlu S., Bartley G.B., and Gibson L.E. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 129 (2000) 651-657
85. Bullock J.D., Bartley G.B., Campbell R.J., et al. Necrobiotic xanthogranuloma with paraproteinemia: case report and a pathogenetic theory. Trans Am Ophthalmol Soc 84 (1986) 342-354
86. Mehregan D.A., and Winkelmann R.K. Necrobiotic xanthogranuloma. [erratum appears in Arch Dermatol 1992;128:632]. Arch Dermatol 128 (1992) 94-100
87. Chave T.A., and Hutchinson P.E. Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation. Clin Exp Dermatol 26 (2001) 493-496
88. Lebey P.B., Determer I., Bazex J., el Sayed F., and Marguery M.C. Periorbital papules and nodules. Necrobiotic xanthogranuloma. Arch Dermatol 133 (1997) 99 102
89. Dubreuilh W. Fibromes miliaries follicularies: Sclerodermie consecutive. Arch Dermatol Syph 7 (1906) 569-570
90. Gottron H.A. Skleromyxodem (Eine eigenartige Erscheinungsform von Myxothesaurodermie). Arch Dermatol Syph 199 (1954) 71-91
91. Godby A., Bergstresser P.R., Chaker B., and Pandya A.G. Fatal scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 38 (1998) 289-294
92. Jackson E.M., and English III J.C. Diffuse cutaneous mucinoses. Dermatol Clin 20 (2002) 493-501
93. Dinneen A.M., and Dicken C.H. Scleromyxedema. J Am Acad Dermatol 33 (1995) 37-43
94. Pomann J.J., and Rudner E.J. Scleromyxedema revisited. Int J Dermatol 42 (2003) 31-35
95. Virchow R. Die Cellularpathologie inihrer Begründung auf physiologische and pathologische Gewebelehre (1858), A. Hirschwald, Berlin
96. Mullins K.J., Meyers S.P., Kazee A.M., Powers J.M., and Maurer P.K. Primary solitary amyloidosis of the spine: a case report and review of the literature. Surg Neurol 48 (1997) 405-408
97. van der Waal R.I., van de Scheur M.R., Huijgens P.C., Starink T.M., and van der Waal I. Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 (2002) 444-447
98. Bayer-Garner I.B., and Smoller B.R. AL amyloidosis is not present as an incidental finding in cutaneous biopsies of patients with multiple myeloma. Clin Exp Dermatol 27 (2002) 240-242
99. Breathnach S.M. Amyloid and amyloidosis. J Am Acad Dermatol 18 (1988) 1-16
100. Turner M. Case of a woman whose face and body in two or three weeks' time became covered with a thick crop of short and white downy hair. Med Times Gaz 2 (1865) 507
101. Farina M.C., Tarin N., Grilli R., et al. Acquired hypertrichosis lanuginosa: case report and review of the literature. J Surg Oncol 68 (1998) 199-203
102. Sindhuphak W., and Vibhagool A. Acquired hypertrichosis lanuginosa. Int J Dermatol 21 (1982) 599-601
103. Begany A., and Nagy-Vezekenyi K. Hypertrichosis lanuginosa acquisita. Acta Derm Venereol 72 (1992) 18-19
104. Perez-Losada E., Pujol R.M., Domingo P., et al. Hypertrichosis lanuginosa acquisita preceding extraskeletal Ewing's sarcoma. Clin Exp Dermatol 26 (2001) 182-183
105. Hegedus S.I., and Schorr W.F. Acquired hypertrichosis lanuginosa and malignancy. A clinical review and histopathologic evaluation with special attention to the "mantle" hair of Pinkus. Arch Dermatol 106 (1972) 84-88
106. Hovenden A.L. Acquired hypertrichosis lanuginosa associated with malignancy. Arch Int Med 147 (1987) 2013-2018